AACR 2023

Tepotinib Treatment Inhibits Tumor Growth and Affects Tumor Permeability in an Intracranial PDX Model of MET-Amplified NSCLC Brain Metastasis

Clark | Oral #1146

Xevinapant Plus Avelumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer: Phase 1b Dose-Expansion Results and Exploratory Biomarker Analyses

Chu | Poster #CT202

Development of a Customized Panel With Clinical Application Potential for Transcriptome Analyses in Selected Cancer Types Using FFPE Specimens

D’Urso | Poster #2107

Comprehensive Real-World-Data Based Molecular Profiling and Mapping of Non-Squamous NSCLC Patients to Immune-Checkpoint-Inhibitor Biomarkers

Kloetgen | Poster #6070

Pharmacodynamic and Immunophenotyping Analyses of ATR Inhibitor M1774 in a Phase I Study in Patients With Solid Tumours (DDRiver Solid Tumors 301)

Plummer | Poster #CT272

Peposertib, a DNA-PK Inhibitor, Enhances the Antitumor Efficacy of Anthracyclines in Triple-Negative Breast Cancer Models In Vitro and In Vivo

Revia | Poster #6215

Clinical Genomic Profiling of Colorectal Cancer by Real World Data Mining

Schulze | Poster #2120

Spatial Transcriptomics of Response to Tepotinib Treatment in a Patient With NSCLC

Simard | Poster #6776

A First-in-Human Phase 1 Study of the ATM Inhibitor M4076 in Patients With Advanced Solid Tumors (DDRiver Solid Tumors 410): Part 1A Results

Siu | Poster #CT171

Translational Analyses of ATR Inhibitor M1774 in a Phase I Study in Patients With Solid Tumors (DDRiver Solid Tumors 301)

Tolcher | Poster #CT271

Inhibition of ATM-Dependent Checkpoint Control and DNA Double-Strand Break Repair Enhances the Efficacy of ATR Inhibitors

Turchick | Poster #6212

Development and Validation of a Quantitative Systems Pharmacology Model for Prediction of Preclinical Efficacy of PARP Inhibitors Rucaparib and Talazoparib Combined With the ATR Inhibitor Gartisertib (M4344)

Villette | Oral #5699

Single-Cell Low Pass Whole Genome Sequencing for Copy-Number Profiling in Circulating Tumor Cells From Prostate, Non-Small Cell Lung and Breast Cancers

Wang | Poster #2312

Characterizing and Developing the Clinical Grade Next Generation Sequencing Based Gut Microbiome Assay With the Bioinformatics Solution

Wang | Poster #4704

Anti-Tumor Immunity of M9657, a Conditional CD137 Immune Agonist, Is Correlated With Mesothelin Expression on Tumor Cells

Xu | Poster #4126